Lymphoma: How the tumor escapes the immune response
Researchers formulate new approaches to therapy
2015-07-08
(Press-News.org) Natural killer cells of the immune system can fend off malignant lymphoma cells and thus are considered a promising therapeutic approach. However, in the direct vicinity of the tumor they lose their effect. Scientists of Helmholtz Zentrum München have now elucidated which mechanisms block the natural killer cells and how this blockade could be lifted. The results were recently published in the European Journal of Immunology.
Natural killer cells (NK cells) are part of the immune system and provide an innate immunity against exogenous and altered endogenous structures. This also appears to apply to tumor cells, against which the body could develop immunity as it does against pathogens, e.g. against viruses. Tumors of the lymph nodes, called lymphomas, are malignant neoplasms that originate from the B cells or T cells of the lymphatic system. B cell lymphomas are very difficult to treat - which is why innovative approaches to therapy are needed. Earlier studies have shown that NK cells have the potential to attack B lymphoma cells and are therefore considered a possible approach to new treatment strategies. In the living organism, however, tumor control by NK cells has been found to be clearly limited.
NK cells become functionally impaired in the tumor microenvironment
In their experiments, the team led by Prof. Dr. Ralph Mocikat of the Institute of Molecular Immunology (IMI) at Helmholtz Zentrum München, found that the NK cells in the immediate vicinity of the tumor showed reduced function. If the cells were placed in a normal environment, their function could be restored within a few hours. This suggests that the factors responsible for the inactivation of the NK cells derive from the tumor itself.
An inflammatory cytokine inactivates NK cells - altered surface molecules block immune activation
The scientists engaged in the research project identified two important tumor-specific factors that are associated with impaired NK cell function. First, a specific inflammatory cytokine (IL-10) is indirectly involved in the inactivation of NK cells. Second, the tumor cells develop protective mechanisms against the NK cells. Thus, the research group showed that specific surface molecules of the tumor cells (NKG2D ligands) which NK cells could bind are down-regulated. Consequently, the NK cells lack an important activation mechanism and are no longer able to carry out cytotoxic activity. Despite the inhibitory strategies of the tumor cells, at an early stage the NK cells produce the cytokine interferon-gamma (IFN-γ), the scientists reported. IFN-γ is essential to activate further immune responses that support the fight against the tumor.
Immunotherapy possible using NK cells - with optimization potential
"Our results show that the transfer of NK cells is a possible strategic option to treat B cell lymphoma. According to our findings, this therapeutic approach can be optimized when transferred NK cells are already activated in vitro prior to their injection, thus bypassing the missing activation potential in the tumor microenvironment. An additional injection of IFN-γ or of antibodies against IL-10 could further support the immune activity," said study leader Mocikat.
INFORMATION:
Further Information
Background:
The Wilhelm Sander Foundation supported this project with € 85,000 and gave it a very positive assessment after its completion. The purpose of the foundation is to promote medical research, in particular the fight against cancer. With more than 2000 funded projects and approximately € 220 million in funds distributed since its inception, the Wilhelm Sander Foundation takes a prominent place in medical research funding in Germany. The foundation's endowment comes from the estate of the entrepreneur Wilhelm Sander; in 2015 the foundation is celebrating its 40th anniversary.
Original Publication:
Belting et al. (2015), Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma. European Journal of Immunology, DOI: 10.1002/eji.201445375
As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,300 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.
The Institute of Molecular Immunology (IMI) performs application-oriented basic research at the interface of immunology, oncology and molecular biology. The objectives of the Institute are to elucidate the basic mechanisms of the immune system, to understand the pathogenesis of immunologically mediated diseases and to directly transfer insights gained in basic research into clinical applications. The Institute focuses on developing new personalized treatment strategies for the targeted modulation of the immune system.
Contact for the media:
Department of Communication, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49 89-3187-2238 - Fax: +49 89 3187 3324 - E-mail: presse@helmholtz-muenchen.de
Scientific contact at Helmholtz Zentrum München:
Prof. Dr. med. Ralph Mocikat, Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Institute of Molecular Immunology, Marchioninistr. 25, 81377 München - Phone: +49 89 3187 1302 - E-mail: Mocikat@helmholtz-muenchen.de
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-08
BLOOMINGTON, Ind. -- The number of women across the globe filing patents with the U.S. Patent and Trade Office over the past 40 years has risen fastest within academia compared to all other sectors of the innovation economy, according to a new study from Indiana University.
The analysis, which examined 4.6 million utility patents issued from 1976 to 2013, was led by Cassidy R. Sugimoto, an associate professor of informatics at the School of Informatics and Computing at IU Bloomington.
The results of "The Academic Advantage: Gender Disparities in Patenting" are reported ...
2015-07-08
This news release is available in French. At population level, vaccines contribute to reducing mortality associated with infectious diseases such as measles, diphtheria, tetanus, hepatitis B or bacterial meningitis. The community general physician, at the centre of this preventive strategy, remains the main source of information for families. In an article published in the journal Ebiomedecine, Pierre Verger (Inserm Unit 912, "Economics and Social Sciences Applied to Health and Analysis of Medical Information - SESSTIM") and his collaborators present and analyse the ...
2015-07-08
This news release is available in German.
The oldest known Old World monkey, Victoriapithecus, first made headlines in 1997 when its fossilized skull was discovered on an island in Kenya's Lake Victoria, where it lived 15 million years ago. An international team led by Fred Spoor of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, and University College London (UCL), UK, has now visualized this monkey's brain for the first time: The creature's tiny but remarkably wrinkled brain supports the idea that brain complexity can evolve before ...
2015-07-08
A new study by the University of Leicester has revealed that men are more receptive to goals in the workplace than women.
Using a timed addition task, research from the University's Department of Economics examined the effect of non-binding goals - where no monetary rewards or punishments are associated with success or failure - on effort, and found:
Men are more motivated by achieving goals than women
Goal-setting can generate the same effects on success as monetary incentives
Having a goal leads to better focus and increased speed to complete a task
One hundred ...
2015-07-08
ANN ARBOR, Mich. -- It's a mysterious condition often linked to childbirth that causes distress and discomfort and requires surgery for more than 200,000 women a year - but there's no good way to study it.
Now, researchers at the University of Michigan have developed the first-ever 3D complete computer model to help study treatment for pelvic organ prolapse, a weakening of muscles and ligaments that causes organs like the bladder to drop from their normal place. For many women, the condition causes urinary problems, painful intercourse and uncomfortable pressure.
The ...
2015-07-08
CLEVELAND - July 8, 2015 - A technology whose roots date to the 1800s has the potential to offer an extraordinary new advantage to modern-day medicine. In findings published this month in Nature Communications, Case Western Reserve scientists detail how stereomicroscopy can provide physicians an invaluable diagnostic tool in assessing issues within the gastrointestinal tract.
Originally used by 19th-century photographers to create the illusion of depth in their pictures, stereomicroscopy since has evolved to become a staple of the film and videogame industries. Only ...
2015-07-08
MANHATTAN -- A new study involving a Kansas State University entomologist reveals that the genes of a fruit fly that has plagued American apple producers for more than 150 years is the result of an extremely rapid evolutionary change.
Greg Ragland, assistant professor of entomology, is co-lead author on a study involving biologists at Rice University, the University of Notre Dame and several other universities. The study looked at the processes that cause a new species to emerge, which may threaten existing, economically important crops. Scientists think that strong ...
2015-07-08
Infectious colonies of bacteria called biofilms that develop on chronic wounds and medical devices can cause serious health problems and are tough to treat. But now scientists have found a way to package antimicrobial compounds from peppermint and cinnamon in tiny capsules that can both kill biofilms and actively promote healing. The researchers say the new material, reported in the journal ACS Nano, could be used as a topical antibacterial treatment and disinfectant.
Many bacteria clump together in sticky plaques in a way that makes them difficult to eliminate with ...
2015-07-08
The decline of honey bees has been a major concern globally for the past decade. One of the factors that could be contributing to the decline is the use of insecticides -- specifically neonicotinoids -- that persist in rivers and streams. Researchers now report in the ACS journal Environmental Science & Technology Letters that although sunlight plays an important role in degrading pollutants, its effects on neonicotinoids can diminish dramatically even in shallow water.
Neonicotinoids protect crops from pests, such as whiteflies, beetles and termites. They are a popular ...
2015-07-08
Today Nicotine & Tobacco Research publishes the third in a series of studies on the cost of smoking in California, one of the first US states to implement a comprehensive tobacco control program. Researchers estimated expenditures for smoking-attributable costs (healthcare, lost productivity from illness, and lost productivity from premature mortality) for the year 2009. The total cost came to $18.1 billion, amounting to $487 per California resident and $4,603 per smoker.
In two previous studies, conducted in 1989 and 1999, the annual financial impact of smoking on California's ...
LAST 30 PRESS RELEASES:
[Press-News.org] Lymphoma: How the tumor escapes the immune response
Researchers formulate new approaches to therapy
